FDPS, a key enzyme in the mevalonate pathway, is overexpressed in various malignancies, including prostate cancer, glioblastoma, colon cancer, and pancreatic cancer [55–58]. This evidence concerns the gene FDPS and familial pancreatic carcinoma.